Mengxin Li is a New York based illustrator and motion graphic designer originally from China. She graduated from Savannah College of Art and Design in 2017 with a MFA degree in Illustration. Mengxin enjoys creating conceptual illustration with a sense of humor, she also agrees that motion graphic techniques could bring out a lot of potential for visual storytelling.
Mengxin Li
Animator, illustrator
From this contributor
How autism’s definition has changed over time
Don’t judge this book by its decidedly dull cover: Across its pages, some of the most dramatic changes in the history of autism have played out. This short animation chronicles how a diagnostic manual has defined and redefined autism over the years.
How autism’s definition has changed over time
By
Emma Bryce, Mengxin Li
9 May 2018 | 3 min watch
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read